• Bio Green Med Solution received Nasdaq's October 29, 2026, deficiency notice following 30 consecutive business days below the $1 minimum bid price.
• The 180-day deadline is April 27, 2027; compliance requires closing bids of at least $1 for 10 consecutive business days.
• The notice has no immediate effect on listing or trading; common stock continues trading on Nasdaq under BGMS.
• A proposed reverse stock split, ranging from 1:4 to 1:16, requires shareholder approval and could help restore compliance.
• Failure to regain compliance within the allotted period, including any extensions, would trigger a delisting notice, subject to appeal.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio Green Med Solution Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-049999), on November 04, 2026, and is solely responsible for the information contained therein.